FDA Said GE Healthcare Recalls Trusignal Spo2 Sensors For Issues That May Reduce Defibrillation Energy, Expose Patients To Unintended Voltage
Portfolio Pulse from Charles Gross
The FDA has announced that GE Healthcare is recalling its Trusignal Spo2 Sensors due to issues that may reduce defibrillation energy and expose patients to unintended voltage.
July 28, 2023 | 11:27 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
GE Healthcare, a subsidiary of General Electric, is recalling its Trusignal Spo2 Sensors due to potential health risks. This could negatively impact the company's reputation and sales.
The recall of a product, especially one related to health risks, can lead to a negative perception of the company's brand and potentially decrease sales. This could negatively impact GE's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100